Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation
Medgadget
MARCH 2, 2023
This leads to substantial damage to healthy tissues and too often results in poor outcomes. This will hopefully lead to an FDA approval for its first indication, after which Alpha TAU plans on expanding to other types of cancer and geographic regions such as Europe and Japan. which are currently recruiting patients.
Let's personalize your content